DiagnostykaS.A.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-09-02
Share capital
33 756 500,00 PLN
Activity description

Diagnostyka is a medical laboratory company that offers blood tests, allergy tests, genetic testing, and prenatal testing, with the option for home sample collection. They provide online results and free interpretation of test results, along with various health packages available for purchase. The company also emphasizes preventive health measures and offers consultations through their updated application.

Registered address
ul. Prof. Michała Życzkowskiego 16, 31-864 Kraków, Poland
Website
diag.plWebsite active
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-12592-53112-VFETU-15

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Stock quotes

PLN 159.00
0.00 (0.00%)
159.00160.00159.0010:0012:0014:0016:00
Open
PLN 159.00
High
PLN 160.30
Low
PLN 158.20
Volume
12.75K
Avg. vol.
19.35K
Market cap
PLN 5.37B
P/E ratio
21.06
EPS
PLN 7.55
Shares outstanding
33.76M
52-week
PLN 157.70 – 165.90
Dividend yield
2.77%
Dividend
PLN 4.40
Ex dividend date
Jun 1, 2026
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 184.50mUSD 25.68mUSD 15.50m
Q1 2026USD 181.23mUSD 33.24mUSD 22.30m
Q4 2025USD 155.27mUSD 16.82mUSD 9.26m
Q3 2025USD 153.78mUSD 25.29mUSD 19.60m

Results for Q3 2026:Nov 26, 2026

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 507.73mMedianUSD 92.12kAverageUSD 1.47m
Net profit
This companyUSD 58.54mMedianUSD 2.47kAverageUSD 170.26k
Operating costs
This companyUSD 418.86mMedianUSD 85.17kAverageUSD 1.19m
Assets
This companyUSD 475.99mMedianUSD 40.61kAverageUSD 1.02m

Bank accounts

Registered as a VAT taxpayer on 2010-07-20. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Dec 2, 2021Financial statement published

Public aid

9 public aid cases recorded, with a total value of $1,282,253.

Grant datePurposeGross amountGranting body
Nov 22, 2024
De minimis aid (in accordance with Commission Regulation 2023/2831)
—Małopolska Agencja Rozwoju Regionalnego S.A.
Sep 26, 2024
De minimis aid (in accordance with Commission Regulation 2023/2831)
—STAROSTA POWIATU BIAŁYSTOCKIEGO
Dec 7, 2023
Investment aid for charging or refuelling infrastructure
—Prezes Zarządu Narodowego Funduszu Ochrony Środowiska i Gospodarki Wodnej

European Funds

StartProjectEU co-financingProgramme
2021-01-01
System automatycznej predykcji badań laboratoryjnych oraz optymalizacji kontroli jakości i obciążenia pracy analizatorów działający w oparciu o machine learning
$799,181Program Operacyjny Inteligentny Rozwój

Tenders

46 tenders recorded as contractor: 19 national ($696,789) and 27 EU ($15,160,904).

Publication dateSubjectAmountContracting authority
Aug 28, 2026
Konkurs na udzielenie zamówienia na badania diagnostyki laboratoryjnej, serologii i mikrobiologii wraz z najmem pomieszczeń dla szpitala w Konstancinie-Jeziornie, przy ul. Wierzejewskiego 12.
—Mazowieckie Centrum Rehabilitacji Stocer sp. z o.o.
Jul 29, 2026
Badania genetyczne
$481,833Opolski Oddział Wojewódzki Narodowego Funduszu Zdrowia w Opolu
Jul 8, 2026
KBL/2/2026 - Konkurs ofert w zakresie realizacji badań diagnostycznych – laboratoryjnych i genetycznych dla Instytutu „CZMP”
$176,654Instytut Centrum Zdrowia Matki Polki

Regulatory authorisations

AuthorityTypeStatus
BDO
Waste generation Active

Authorized Representatives

Dariusz Zowczak — Vice President of the Management Board
Marta Rogalska Kupiec — Vice President of the Management Board
Jakub Józef Swadźba — President of the Management Board
Jaromir Pelczarski — Vice President of the Management Board

Manner of representation

If the management board is a multi-member management board, joint action by two members of the management board is required to submit declarations on behalf of the company.

Supervisory board

Aniela Hejnowska — Supervisory Board Member
Artur Olender — Supervisory Board Member
Marcin Fryda — Supervisory Board Member
Grzegorz Jan Głownia — Supervisory Board Member
Jacek Prusek — Supervisory Board Member

Beneficial owners

PersonRights
Paweł Chytła (45)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Jaromir Pelczarski (58)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Marta Dorota Rogalska-Kupiec (54)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Jakub Swadźba (60)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Dariusz Zowczak (62)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).

Subsidiaries

NameShare valueStake
2,147.49 USD100%
184,656.94 USD100%
135,062.13 USD50%

Competitors

NameRevenueWebsite
LUX Medsp. z o.o.$1,206,019,839.28luxmed.pl
Copernicus Podmiot Leczniczysp. z o.o.$345,256,952.03copernicus.gda.pl
American Heart of PolandS.A.$326,403,314.92ahop.pl
PZU ZdrowieS.A.$304,464,409.93pzuzdrowie.pl
Szpital Specjalistyczny Im. Ludwika Rydygiera w Krakowiesp. z o.o.$237,332,771.76szpitalrydygier.pl
ScanmedS.A.$218,907,835.26scanmed.pl
PolmedS.A.$107,913,555.50polmed.pl
Nutrimedsp. z o.o.$64,888,288.93nutrimed.pl
VoxelS.A.$53,719,762.23voxel.pl
Centrum Medyczne Luxmedsp. z o.o.$56,441,775.45luxmed.pl

FAQ

Last updated: 2026-10-01